Skip to main content

Advertisement

SpringerLink
Log in

Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients

  • Pharmacogenetics
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

The P-glycoprotein, a product of MDR1 (multiple drug resistance 1) gene, is a membrane efflux pump localized in epithelial cells in the small and large intestine, a part of the gastrointestinal barrier that protects cells against xenobiotics from our diet, bacterial toxins, drugs and other biologically active compounds, possibly carcinogens. In the present study, an association of MDR1 gene polymorphism and the occurrence of colon cancer were evaluated.

Methods

The study population consisted of 184 unrelated sporadic colon cancer patients and 188 healthy unrelated controls. Colon cancer patients were also subdivided into two subgroups, i.e., diagnosed before and after 50 years of age, and compared with age-stratified controls. The C3435T MDR1 gene polymorphism was identified using the polymerase chain reaction–restriction fragment length polymorphism method.

Results

The distribution of wild-type and mutated genotypes was similar in the colon cancer patients and in the healthy controls. However, when patients diagnosed before 50 years of age were compared with the healthy population, carriers of MDR1 3435TT genotype or 3435T allele were at 2.7-fold (P<0.05) and 1.7-fold (P<0.05) higher risk of the disease development, respectively.

Conclusions

Genetic testing for C3435T MDR1 gene polymorphism may be a suitable test to evaluate the risk for colon cancer in patients under 50 years of age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cascorbi I, Gerloff Th, Johne A, Meisel CH, Hoffmeyer S, Schwab M et al (2001) Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 69:169–174

    Google Scholar 

  2. Doll R (1996) Nature and nurture: possibilities for cancer control. Carcinogenesis 17:177–184

    CAS  PubMed  Google Scholar 

  3. Droździk M, Białecka M, Myśliwiec K, Honczarenko K, Stankiewicz J, Sych Z (2003) Polymorphism in the P-glycoprotein drug transporter MDR1 gene—a possible link between environmental and genetic factors in Parkinson’s disease. Pharmacogenetics 13:259–263

    Article  PubMed  Google Scholar 

  4. Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave J-P et al (2002) Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 359:30–36

    Article  CAS  PubMed  Google Scholar 

  5. Fujita M, Furukawa Y, Tsunoda T, Tanaka T, Ogawa M, Nakamura Y (2001) Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the β-catenin/T-cell factor complex, in colorectal carcinomas. Cancer Res 61:722–726

    Google Scholar 

  6. Grady WM (2003) Genetic testing for high-risk colon cancer patients. Gastroenterology 124:1574–1594

    Article  CAS  PubMed  Google Scholar 

  7. Hitzl M, Drescher S, van der Kuip H, Schaffeler E, Fischer J, Schwab M et al (2001) The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 11:293–298

    Google Scholar 

  8. Hlubek F, Jung A, Kotzor N, Kirchner T, Brabletz T (2001) Expression of the invasion factor laminin γ2 in colorectal carcinomas is regulated by β-catenin. Cancer Res 61:8089–8093

    CAS  PubMed  Google Scholar 

  9. Ho G-T, Moodie FM, Satsangi J (2003) Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease. Gut 52:759–766

    Article  CAS  PubMed  Google Scholar 

  10. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A et al (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 97:3473–3478

    Google Scholar 

  11. Humeny A, Rodel F, Rodel C, Sauer R, Fuzesi L, Becker C et al (2003) MDR1 single nucleotide polymorphism C3435T in normal colorectal tissue and colorectal carcinomas detected by MALDI-TOF mass spectrometry. Anticancer Res 23:2735–2740

    CAS  PubMed  Google Scholar 

  12. Jho E, Zhang T, Domon C, Joo CK, Freund JN, Costantini F (2002) Wnt/beta-catenin/tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22:1172–1183

    Article  CAS  PubMed  Google Scholar 

  13. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159–170

    CAS  PubMed  Google Scholar 

  14. Koh TJ, Bulitta CJ, Fleming JV, Dockray GJ, Varro A, Wang TC et al (2000) Gastrin as a target of the beta-catenin/TCF-4 growth-signalling pathway in a model of intestinal polyposis. J Clin Invest 106:533–539

    CAS  PubMed  Google Scholar 

  15. Lotsch J, Skarke C, Geisslinger G (2003) Simultaneous screening for three mutations in the ABCB1 gene. Genomics 82:503–510

    Article  CAS  PubMed  Google Scholar 

  16. Maggio-Price L, Shows D, Waggle K, Burich A, Zeng W, Escobar S et al (2002) Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1−/−) mice. Am J Pathol 160:739–751

    CAS  PubMed  Google Scholar 

  17. Nakamura T, Sakaeda T, Horinouchi M, Tamura T, Aoyama N, Shirakawa T et al (2002) Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther 71:297–303

    Article  CAS  PubMed  Google Scholar 

  18. Panwala CM, Jones JC, Viney JL (1998) A novel model of inflammatory bowel disease: mice deficient for the multiple resistance gene, mdr1a, spontaneously develop colitis. J Immunol 161:5733–5744

    CAS  PubMed  Google Scholar 

  19. Rund D, Zaar I, Sheperling O (1999) A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease. Adv Exp Med Biol 457:71–75

    CAS  PubMed  Google Scholar 

  20. Schaeffeler E, Eichelbaum M, Brinkmann U, Penger A, Asante-Poku S, Zanger S et al (2001) Frequency of 3435T polymorphism of MDR1 gene in African people. Lancet 358:383–384

    Article  CAS  PubMed  Google Scholar 

  21. Schinkel AH (1997) The physiological function of drug-transporting P-glycoproteins. Semin Cancer Biol 8:161–170

    Article  CAS  PubMed  Google Scholar 

  22. Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J et al (2003) Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 124:26–33

    CAS  PubMed  Google Scholar 

  23. Shields PG, Harris CC (2000) Cancer risk factor and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18:2309–2315

    CAS  PubMed  Google Scholar 

  24. Siegsmung M, Brinkmann U, Scheffeler E, Weirich G, Schwab M, Eichelbaum M et al (2002) Association of the P-glycoprotein transporter MDR1 (C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol 13:1847–1854

    Article  PubMed  Google Scholar 

  25. Stein U, Walther W, Wunderlich V (1994) Point mutations in the MDR1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs. Eur J Cancer 30A:1541–1545

    Article  Google Scholar 

  26. Tanabe M, Ieiri I, Nagata N, Inoue K, Ito S, Kanamori Y et al (2001) Expression of p-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 297:1137–1143

    Google Scholar 

  27. Tang K, Ngoi SM, Gwee PC, Chua JM, Lee EJ, Chong SS et al (2002) Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics 12:437–450

    Google Scholar 

  28. Tanigawara Y (2000) Role of P-glycoprotein in drug disposition. Ther Drug Monit 22:137–140

    Article  CAS  PubMed  Google Scholar 

  29. Taniguchi S, Mochida Y, Uchiumi T, Tahira T, Hayashi K, Takagi K et al (2003) Genetic polymorphism at the 5′ regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon. Mol Cancer Ther 2:1351–1359

    CAS  PubMed  Google Scholar 

  30. Wong NA, Pignatelli M (2002) Beta-catenin: a linchpin in colorectal carcinogenesis?. Am J Pathol 160:389–401

    CAS  PubMed  Google Scholar 

  31. Yamada T, Takaoka AS, Naishiro Y, Hayashi R, Maruyama K, Maesawa C et al (2000) Transactivation of the multidrug resistance 1 gene by T-cell factor 4/ β-catenin complex in early colorectal carcinogenesis. Cancer Res 60:4761–4766

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Janina Suchy is the recipient of a scholarship from the Postgraduate School of Molecular Biology affiliated with the Medical University in Warsaw.

Author information

Authors and Affiliations

  1. Department of Pharmacology, Pomeranian Medical University, Powstańców Wlkp. 72 Str, 70-111, Szczecin, Poland

    Mateusz Kurzawski, Marek Droździk, Monika Białecka & Wanda Górnik

  2. Hereditary Cancer Center, Department of Genetics and Patomorphology, Pomeranian Medical University, Szczecin, Poland

    Janina Suchy, Grzegorz Kurzawski & Jan Lubiński

Authors
  1. Mateusz Kurzawski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marek Droździk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Janina Suchy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Grzegorz Kurzawski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Monika Białecka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wanda Górnik
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jan Lubiński
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mateusz Kurzawski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurzawski, M., Droździk, M., Suchy, J. et al. Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol 61, 389–394 (2005). https://doi.org/10.1007/s00228-005-0926-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-005-0926-5

Keywords

Search

Navigation